Coronary artery disease (CAD) is the leading cause of death in the United States. Although effective preventive treatments ...

Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...

The European Commission has today communicated that it has granted BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai's application for Marketing Authorization of ...

A Certified Athletic Trainer Unveils the Ageless Knees Program—A Non-Invasive, At-Home Solution That Targets Femoral Nerve ...

Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney ...

In addition to development in nrSPMS per the HERCULES trial, there is an ongoing Phase III study to investigate the efficacy ...

“The clinical community now has an FDA-approved therapeutic innovation for patients that targets underlying disease mechanisms and helps to control disease activity by reducing flares in IgG4-RD ...

1 Yet, when the liver doesn’t function properly, it can lead to liver disease — a broad category ... is the driving force behind true progress for people living with chronic liver conditions.

KBRA assigns preliminary ratings to eight classes of Progress Residential 2025-SFR3 ... The aggregate BPO value of the underlying homes is $782.4 million, yielding an LTV of 99.5%.

A blood test developed to detect Alzheimer’s disease can also show how far the disease has progressed and tell if symptoms are due to Alzheimer’s or another cause, a study finds. The report ...